NCT00715273View on ClinicalTrials.gov

Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication

PHASE4CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

May 1, 2001

Primary Completion Date

December 12, 2018

Study Completion Date

March 1, 2019

Conditions
Coronary Artery DiseaseCarotid Artery DiseasesAtherosclerosis
Interventions
DRUG

Atorvastatin

10 to 80 mg of atorvastatin each day

DRUG

Niacin

2000 mg of niacin each day

DRUG

Colesevelam

3.8 g of colesevelam each day

DRUG

Placebo Niacin

Placebo niacin each day

DRUG

Placebo Colesevelam

Placebo colesevelam each day

Trial Locations (4)

83712

St. Luke's Idaho Cardiology, Boise

90089

University of Southern California, Los Angeles

98104

University of Washington Coronary Atherosclerosis Research Lab, Seattle

98902

Yakima Heart Center, Yakima

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Pfizer

INDUSTRY

collaborator

Abbott

INDUSTRY

collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Upsher-Smith Laboratories

INDUSTRY

lead

University of Washington

OTHER